Our Recent Posts


No tags yet.

Outlook for global M&A

Global M&A had another strong showing in 2019. The deal volume and value recorded was even more impressive given the uncertainty which has haunted the global economy over the last few years. The looming threat of a global recession, stock market pullbacks, increasing trade disputes, heightened national security and competition concerns, sluggish economic growth and political uncertainty had an impact, yet dealmaking remained robust. The $27bn purchase of Refinitiv by the London Stock Exchange, the $74bn merger between Bristol-Myers Squibb and Celgene, and Salesforce’s $15.7bn